ReviewFlibanserin: From Bench to Bedside
Under a Creative Commons license
open access
Key Words
Female Sexual Dysfunction
Hypoactive Sexual Desire Disorder
Flibanserin
Food and Drug Administration
Cited by (0)
Conflicts of Interest: Dr Dooley and Dr Miller report no conflicts of interest. Dr Clayton has received grants from Auspex Pharmaceuticals, Axsome, Forest Research Institute, Inc, Genomind, Inc, Janssen, Palatin Technologies, and Takeda; has been on the advisory board fee or received a consultant fee from Fabre-Kramer, Palatin Technologies, S1 Biopharma, Sprout (division of Valeant Pharmaceuticals), and Takeda; has received royalties or owns copyrights from Ballantine Books/Random House, Changes in Sexual Functioning Questionnaire, and Guilford Publications; and owns shares or restricted stock units in Euthymics and S1 Biopharma.
Funding: None.
© 2017 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.